Company Overview
CVP Diagnostics (Boston, Massachusetts) is a privately held medical device company dedicated to improving the control of heart failure. The company was founded with the vision of developing a noninvasive method to measure left ventricular end-diastolic pressure (LVEDP), the primary hemodynamic parameter for the recognition and management of heart failure.
The company’s breakthrough technology, VeriCor® monitor, was recently cleared by the U.S. FDA for use in estimating non-invasively left ventricular end-diastolic pressure. The VeriCor® monitor can provide hemodynamic monitoring at the community level for the first time to optimize the treatment of ambulatory heart failure patients.
The company has maintained an aggressive approach to enhancing intellectual property protection. The company has a range of intellectual property rights in Europe, Canada and Japan in addition to the United States.
The VeriCor® monitor is about to be commercialized and has the potential to revolutionize the treatment of heart failure.
|
